Explore / Clinical trial
Clinical trial

Trifecta Research Study

Johns Hopkins UniversityWithdrawnPhase 2Started Sep 1, 20250 enrolledUnited StatesNCT06810765

Abstract

The Special Operations Care-Fund (SOC-F) will sponsor the application of four treatments - hormone replacement, magnetic resonance brain stimulation, ibogaine, and 5-Meo-DMT - to Special Operations Forces veterans with a history of combat deployments, traumatic brain injury, and problems with mental health and cognitive functioning. An observational study will be conducted in parallel by the Johns Hopkins Center for Psychedelic and Consciousness Research to determine the effectiveness and safety of each treatment, primarily through measuring post-treatment changes in PTSD symptoms and cognitive functioning.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

IbogainePTSD

Keywords

military veterancognitive functioningTraumatic Brain Injury (TBI)psychedelicsTranscranial Magnetic Stimulation (TMS)PTSD - Post Traumatic Stress DisorderCognitive DysfunctionBrain TraumaBrain Injuries

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.